PreciseDx

PreciseDx is at the forefront of medical and diagnostic innovation, particularly in oncology. Located at 810 7th Ave, 515, New York, NY 10019, US, PreciseDx is revolutionizing disease analysis through the integration of Artificial Intelligence (AI) with its patented Morphology Feature Array® (MFA). This powerful combination provides unmatched disease insights and delivers accurate, actionable intelligence, enabling more comprehensive decision-making throughout the cancer care continuum.

PreciseDx is dedicated to advancing oncology diagnostics. With its innovative approach, PreciseDx empowers healthcare professionals with the tools they need to make informed decisions, ultimately improving patient outcomes in the fight against cancer. The company’s commitment to innovation and excellence positions it as a key player in the future of oncology diagnostics.

PreciseDx's commitment to advancing the field is unwavering, and further details about their cutting-edge work will be shared soon with insights provided by the company's management. We invite the management team at PreciseDx to create a customized and exclusive company showcase and product listing on our platform to highlight their groundbreaking contributions.